← Leaderboards
Frank E Jones
Tulane University Of Louisiana
$5,175,445
Attributed
$5,175,445
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $724.2K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,175,445 · 2
By mechanism
R01$5,175,445 · 2
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Carol J Phelps$470,534
- Charles A Miller$1,199,269
- David L. Hurley$290,333
Others in their field
Top investigators on “Mammary Gland”
- Jeffrey Rosen · Baylor College Of Medicine$19,572,228
- Lewis A Chodosh · University Of Pennsylvania$17,627,328
- Zena Werb · University Of California San Francisco$15,282,178
- Stanley R Hamilton · Johns Hopkins University$15,095,357
- John J Wysolmerski · Yale University$14,975,740
- Bert W O'Malley · Baylor College Of Medicine$14,351,952
Research focus
Mammary GlandCell ProliferationSignal TransductionNeoplasm /Cancer GeneticsReceptor Protein-Tyrosine KinasesResearch StudyTumorErbb4 GeneMutantFamily MemberNeoplastic CellOncogenesBreastLaboratory MouseMediatingLactationMammary NeoplasmsNeoplasticMemberEpidermal Growth Factor ReceptorFamilyClinical ResearchCoupledMalignant Neoplasms
Grant awards (25)
ERBB4 in the Normal and Neoplastic Breast$241,233
R01 · FY2013 · CA · contact PI
ERBB4 in the Normal and Neoplastic Breast$256,631
R01 · FY2012 · CA · contact PI
ERBB4 in the Normal and Neoplastic Breast$256,631
R01 · FY2011 · CA · contact PI
ERBB4 in the Normal and Neoplastic Breast$264,129
R01 · FY2010 · CA · contact PI
ERBB4 in the Normal and Neoplastic Breast$46,218
R01 · FY2010 · CA · contact PI
ERBB4 in the Normal and Neoplastic Breast$269,842
R01 · FY2009 · CA · contact PI
ERBB4 signaling in the normal and neoplastic breast$262,836
R01 · FY2008 · CA · contact PI
Influence of ErbB4 activity on metastatic breast cancer$304,122
R01 · FY2007 · CA · contact PI
ERBB4 signaling in the normal and neoplastic breast$249,517
R01 · FY2007 · CA · contact PI
Influence of ErbB4 activity on metastatic breast cancer$6,854
R01 · FY2007 · CA · contact PI
Influence of ErbB4 activity on metastatic breast cancer$276
R01 · FY2007 · CA · contact PI
Influence of ErbB4 activity on metastatic breast cancer$320,203
R01 · FY2006 · CA · contact PI
ERBB4 signaling in the normal and neoplastic breast$252,963
R01 · FY2006 · CA · contact PI
ERBB4 signaling in the normal and neoplastic breast$110,927
R01 · FY2006 · CA · contact PI
Influence of ErbB4 activity on metastatic breast cancer$40,095
R01 · FY2006 · CA · contact PI
Influence of ErbB4 activity on metastatic breast cancer$324,024
R01 · FY2005 · CA
ERBB4 signaling in the normal and neoplastic breast$263,153
R01 · FY2005 · CA
Influence of ErbB4 activity on metastatic breast cancer$63,989
R01 · FY2005 · CA
Influence of ErbB4 activity on metastatic breast cancer$326,312
R01 · FY2004 · CA
ERBB4 signaling in the normal and neoplastic breast$259,050
R01 · FY2004 · CA
Influence of ErbB4 activity on metastatic breast cancer$58,905
R01 · FY2004 · CA
Influence of ErbB4 activity on metastatic breast cancer$323,981
R01 · FY2003 · CA
ErbB4 signaling in the normal and neoplastic breast$221,938
R01 · FY2003 · CA
ErbB4 signaling in the normal and neoplastic breast$217,390
R01 · FY2002 · CA
ErbB4 signaling in the normal and neoplastic breast$234,226
R01 · FY2001 · CA